Li J, Shi LW, Yu BW, Huang LR, et al. Safety and immunogenicity of a pichia pastoris-expressed bivalent human papillomavirus (types 16 and 18) L1 virus-like particle vaccine in healthy Chinese women aged 9-45 years: A randomized, double-blind, placebo-controlled phase 1 clinical trial. Vaccine 2023 Apr 13:S0264-410X(23)00392-4. doi: 10.1016/j.vaccine.2023.
PMID: 37061370